FindTrial
Sign In

A retrospective analysis of patients with renal transplantation with voriconazole in antifungal therapy

A retrospective analysis of patients with renal transplantation with voriconazole in antifungal therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RRC-16008314
Enrollment
Unknown
Registered
2016-04-19
Start date
2016-04-25
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fungal infection

Interventions

High rise group:Artificial division
Low rise group:Artificial division

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age more than 18 years

Exclusion criteria

Exclusion criteria: 1) the severe liver function; 2)combination of rifampicin and isoniazid phenytoin, carbamazepine, long-acting barbiturate; 3) the disease healed requirements discharged or transferred to other hospital patient.

Design outcomes

Primary

MeasureTime frame
Blood concentration;Clinical index;Dosage;—

Countries

China

Contacts

Public ContactZhang Bikui
bikui_zh@126.com+86 13973116871

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026